Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Kevin Alby, PhD

Kevin Alby, PhD Pathologist

Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Dr. Alby is employed by Penn Medicine.

Clinical Specialties


  • Pathology and Laboratory Medicine

Programs & Centers:

Description of Clinical Expertise

I help direct the Clinical Microbiology Laboratory at HUP. My areas of focus are on implementation of new technology such as multiplex PCR assays and MALDI-TOF mass spectrometry.

Practice Locations and Appointments

Insurance Accepted

  • OPR Medicare
  • OPR New Jersey Medicaid
  • OPR Pennsylvania Medicaid

Education and Training

Graduate School: Brown University
Fellowship: University of North Carolina Hospitals


American Society for Clinical Pathology, National American Society of Microbiology, International ASM/CDC/FDA, National Association for Molecular Pathology, National City of Philadelphia , Local Clinical Laboratory Standards Institute, International Eastern PA Branch of the American Society for Microbiology, Local Pan-American Society for Clinical Virology, International

Hospital Affiliation

Dr. Alby is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Description of Research Expertise:

My research focuses on the utilization, development, and validation of tests for the Clinical Microbiology Laboratory at HUP. My two major focuses are on using new technologies such as MALDI-TOF to identify resistant bacteria sooner and the development and utilization of molecular tests to detect viral illnesses.

Selected Publications:

Mitchell SL and Alby K: Performance of Microbial Identification by MALDI-TOF MS and Susceptibility Testing by VITEK 2 from Positive Blood Cultures after Minimal Incubation on Solid Media European Journal of Clinical Microbiology and Infectious Diseases 36 (11): 2201-2206,2017.

Gomez EJ, Roberts AL, Robinson DP, Alby K, Ledeboer NA, Doern CD, Lander DW, Bearman G, and Sullivan KV: Impact of Organism Identification Method on Central Line-associated Bloodstream Infection Designation Infection Control and Hospital Epidemiology 38 (8): 1007-1009,2017.

Mitchell SL, Mattei LM, and Alby K: Whole Genome Characterization of a Naturally Occurring Vancomycin-dependent Enterococcus faecium from a Patient with Bacteremia Infection, Genetics, and Evolution (52): 96-99,2017.

Ma GK, Pegues DA, Kochman ML, Alby K, Fishman NO, Saunders M, Grous C, Dempsey DT, and Ginsberg GG: Implementation of a Systematic Culturing Program to Monitor Efficacy of Endoscope Reprocessing: Outcomes and Costs Gastrointestinal Endoscopy : 2017.

Mills JP, Wilck MB, Weikert BC, Porrett PM, Timko D, Alby K, Bonomo RA, and Blumberg EA: Successful Treatment of a Disseminated Infection with Extensively Drug-resistant Klebsiella pneumonia in a Liver Transplant Recipient with a Fosfomycin-based Multidrug Regimen Transplant Infectious Disease 18 (5): 777-781,2016.

Mills JP, Talati NJ, Alby K, and Han JH: The Epidemiology of Carbapenem-Resistant Klebsiella pneumonaie Colonization and Infection among Long-Term Acute Care Hospital Residents Infection Control and Hospital Epidemiology 37 (1): 55-60,2016.

Glaser L, Andreacchio K, Lyons M, and Alby K: Improved Surveillance for Carbapenem Resistant Enterobacteriaceae using Chromogenic Media with a Broth Enrichment Diagnostic Microbiology and Infectious Disease 82 (4): 284-5,2015.

Tran A, Alby K, Kerr A, Jones M, and Gilligan PH: Cost Savings Incurred by Implementation of Routine Microbiological Identification by Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry Journal of Clinical Microbiology 53 (8): 2473-9,2015.

Chambers BS, Parkhouse K, Ross TM, Alby K, and Hensley SE: Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season Cell Reports 12 (1): 1-6,2015.

Roshdy DG, Tran A, LeCroy N, Zeng D, Ou FS, Daniels LM, Weber DJ, Alby K and Miller MB: Impact of a Rapid Microarray Assay for Identification of Positive Blood Cultures on Treatment Optimization for Patients with Streptococcal and Enterococcal Bacteremia Journal of Clinical Microbiology 53 (4): 1411-4,2015.

Academic Contact Info

3400 Spruce Street
4th Floor, Gates Building

Philadelphia, Pa 19104
Phone: (215) 662-6652
Patient appointments: 800-789-7366 (PENN)